Table 6.
Immune related adverse effect.
| Grade I | Grade II | |
|---|---|---|
| Cutaneous rash | 5 (45.5%) | 1 (9.1%) |
| Fatigue | 3 (27.3%) | 0 |
| Nausea | 1 (9.1%) | 0 |
| Reactive cutaneouscapillary endothelial proliferation | 3 (27.3%) | 1 (9.1%) |
| Anemia | 1 (9.1%) | 1 (9.1%) |
| Liver malfunction | 2 (18.2%) | 0 |
| Pruritus | 1 (9.1%) | 0 |